Compass Therapeutics has hired Barry Shin as the clinical-stage biopharmaceutical company's new chief financial officer. Compass on Tuesday said Shin most recently served as executive vice ...
BOSTON - Compass Therapeutics, Inc. (NASDAQ:CMPX), a biopharmaceutical company engaged in the development of antibody-based treatments for cancer and other diseases, announced Monday the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果